BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10785474)

  • 1. Elevated serum CA-125 levels in hemodialysis patients with peritoneal, pleural, or pericardial fluids.
    Sevinc A; Buyukberber S; Sari R; Kiroglu Y; Turk HM; Ates M
    Gynecol Oncol; 2000 May; 77(2):254-7. PubMed ID: 10785474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum, pleural effusion, and ascites CA-125 levels in ovarian cancer and nonovarian benign and malignant diseases: a comparative study.
    Topalak O; Saygili U; Soyturk M; Karaca N; Batur Y; Uslu T; Erten O
    Gynecol Oncol; 2002 Apr; 85(1):108-13. PubMed ID: 11925128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity.
    Lazzarino M; Orlandi E; Klersy C; Astori C; Brusamolino E; Corso A; Bellio L; Gargantini L; Morra E; Bernasconi C
    Cancer; 1998 Feb; 82(3):576-82. PubMed ID: 9452277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion].
    Jibiki K; Demura R; Abe Y; Odagiri E; Demura H
    Gan No Rinsho; 1987 Nov; 33(14):1756-62. PubMed ID: 3480363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CA 125, carcinoembryonic antigen, and CA 19-9 as tumor markers in borderline ovarian tumors.
    Engelen MJ; de Bruijn HW; Hollema H; ten Hoor KA; Willemse PH; Aalders JG; van der Zee AG
    Gynecol Oncol; 2000 Jul; 78(1):16-20. PubMed ID: 10873403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [High Ca 125 serum level in benign ascites or pleural effusion].
    Mezger J; Häussinger KE; Wilmanns W; Lamerz R
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):463-5. PubMed ID: 3476336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures.
    Elia S; Massoud R; Guggino G; Cristino B; Cortese C; De Massimi AR; Zenobi R
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):723-7. PubMed ID: 18261916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor alpha levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma.
    Sedlaczek P; Frydecka I; Gabryś M; Van Dalen A; Einarsson R; Harłozińska A
    Cancer; 2002 Nov; 95(9):1886-93. PubMed ID: 12404282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal fluid lactate dehydrogenase in ovarian cancer.
    Schneider D; Halperin R; Langer R; Bukovsky I; Herman A
    Gynecol Oncol; 1997 Sep; 66(3):399-404. PubMed ID: 9299252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid.
    Turk HM; Pekdemir H; Buyukberber S; Sevinc A; Camci C; Kocabas R; Tarakcioglu M; Buyukberber NM
    Tumour Biol; 2003; 24(4):172-5. PubMed ID: 14654710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of renal function on serum levels of CA 125.
    Menzin AW; Kobrin S; Pollak E; Goodman DB; Rubin SC
    Gynecol Oncol; 1995 Sep; 58(3):375-7. PubMed ID: 7672704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum CA 125 concentration in patients with tuberculous peritonitis: a case-control study.
    Simsek H; Savas MC; Kadayifci A; Tatar G
    Am J Gastroenterol; 1997 Jul; 92(7):1174-6. PubMed ID: 9219793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum CA-125 measurements > 65 U/mL. Clinical value.
    Eltabbakh GH; Belinson JL; Kennedy AW; Gupta M; Webster K; Blumenson LE
    J Reprod Med; 1997 Oct; 42(10):617-24. PubMed ID: 9350014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Usefulness of CEA, CA 15-3 and CA 125 tumor markers in the differential diagnostics of peritoneal effusion].
    Kiluk MS; Rółkowski R; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Oct; 13(76):298-301. PubMed ID: 12557435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma.
    Sevinc A; Camci C; Turk HM; Buyukberber S
    Oncology; 2003; 65(1):1-6. PubMed ID: 12837976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tumor markers in patients on dialysis and kidney transplantation.
    Lye WC; Tambyah P; Leong SO; Lee EJ
    Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between soluble tumor necrosis factor receptors and CA125 in peritoneal fluids as a marker for epithelial ovarian cancer.
    Onsrud M; Shabana A; Austgulen R; Nustad K
    Gynecol Oncol; 1995 May; 57(2):183-7. PubMed ID: 7729731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CA 125 in peritoneal fluid: reliable values at high dilutions.
    Barbati A; Anceschi MM; Di Renzo GC; Cosmi EV
    Obstet Gynecol; 1992 Jun; 79(6):1011-5. PubMed ID: 1579297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of serum levels of tumor markers with tissue expression of gene products in ovarian carcinoma.
    Sorak M; Arsenijević S; Lukić G; Arsenijević N; Ristić P; Pavlović S; Popović S; Baskić D
    J BUON; 2007; 12(1):99-104. PubMed ID: 17436409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of epithelial ovarian cancer recurrence in patients with rising serum CA-125 levels within the normal range.
    Santillan A; Garg R; Zahurak ML; Gardner GJ; Giuntoli RL; Armstrong DK; Bristow RE
    J Clin Oncol; 2005 Dec; 23(36):9338-43. PubMed ID: 16361633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.